Assessing osteoporosis risk factors in Spanish menopausal women

References

• Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008;19:399–428.
   PubMed Web of Science ®Google Scholar
• Holroyd C, Cooper C, Dennison E. Epidemiology of osteoporosis. Best Pract Res Clin Endocrinol Metab 2008;22:671–685.
   PubMed Web of Science ®Google Scholar
• Winsloe C, Earl S, Dennison EM, Cooper C, Harvey NC. Early life factors in the pathogenesis of osteoporosis. Curr Osteoporos Rep 2009;7:140–144.
   PubMedGoogle Scholar
• Ioannidis G, Thabane L, Gafni A, Hodsman A, Kvern B, Johnstone D, Plumley N, Salach L, Jiwa F, Adachi JD, Papaioannou A. Optimizing care in osteoporosis: The Canadian quality circle project. BMC Musculoskelet Disord 2008;9:130.
   Google Scholar
• Lewiecki EM. Management of osteoporosis. Clin Mol Allergy 2004;2:9–19.
   Google Scholar
• Keramat A, Patwardhan B, Larijani B, Chopra A, Mithal A, Chakravarty D, Adibi H, Khosravi A. The assessment of osteoporosis risk factors in Iranian women compared with Indian women. BMC Musculoskelet Disord 2008;9:28–37.
   PubMedGoogle Scholar
• de Oliveira Ferreira N, Arthuso M, da Silva R, Pedro AO, Neto AM, Costa-Paiva L. Quality of life in women with postmenopausal osteoporosis: correlation between QUALEFFO 41 and SF-36. Maturitas 2009;20:85–90.
   Google Scholar
• Navarro MC, Sosa M, Saavedra P, Lainez P, Marrero M, Torres M, Medina CD. Poverty is a risk factor for osteoporotic fractures. Osteoporos Int 2009;20:393–398.
   Web of Science ®Google Scholar
• Nayak S, Roberts MS, Greenspan SL. Factors associated with osteoporosis screening and recommendations for osteoporosis screening in older adults. J Gen Intern Med 2009;24:585–591.
   PubMed Web of Science ®Google Scholar
• Alvarez C, Alonso J, Domingo A, Regidor E. La medición de la clase social en Ciencias de la Salud: informe de un grupo de trabajo de la Sociedad Española de Epidemiología. Barcelona, Spain: SG Editores S.A. 1995
   Google Scholar
• Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N. Executive summary: stages of reproductive aging workshop (STRAW) Park City, Utah, July 2001. Menopause 2001;8:402–407.
   PubMedGoogle Scholar
• Kupperman HS, Wetcheler BB, Blat MH. Contemporary therapy of the menopausal syndrome. JAMA 1959;171:1627–1637.
   PubMed Web of Science ®Google Scholar
• Blotman F, Cortet B, Hilliquin P, Avouac B, Allaert FA, Pouchain D, Gaudin AF, Cott FE, Hasnaoui A. Characterisation of patients with postmenopausal osteoporosis in French primary healthcare. Drugs Aging 2007;24:603–614.
   Google Scholar
• Dumitrescu B, Van Helden S, Ten Broeke R, Nieuwenhuijzen-Kruseman A, Wyers C, Udrea G, van der Linden S, Geusens P. Evaluation of patients with clinical fracture and osteoporosis, a multidisciplinary approach. BMC Musculoskelet Disord 2008;9:109–119.
   Google Scholar
• Rentero ML, Carbonell C, Casillas M, González M, Berenguer R. Risk factors for osteoporosis and fractures in postmenopausal women between 50 and 65 years of age in a primary care setting in Spain: a questionnaire. Open Rheumatol J 2008;2:58–63.
   Google Scholar
• Chen JS, Hogan C, Lyubomirsky G, Sambrook PN. Management of osteoporosis in primary care in Australia. Osteoporos Int 2009;20:491–496.
   Google Scholar
• Czerwiński E, Badurski JE, Marcinowska-Suchowierska E, Osieleniec J. Current understanding of osteoporosis according to the position of the World Health Organization (WHO) and International Osteoporosis Foundation. Ortop Traumatol Rehabil 2007;9:337–356.
   PubMedGoogle Scholar
• Perreault S, Dragomir A, Blais L, Moride Y, Rossignol M, Ste-Marie LG, Fernandes JC. Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture. Pharmacoepidemiol Drug Saf 2008;17:248–259.
   PubMed Web of Science ®Google Scholar
• Coutinho SF, Fletcher A, Bloch V, Rodrigues C. Risk factors for falls with severe fracture in elderly people living in a middle-income country: a case control study. BMC Geriatr 2008;8:21–27.
   PubMedGoogle Scholar
• Basset JH, ÓShea PJ, Sriskantharajah S, Rabier B, Boyde A, Howell PG, Weiss RE, Roux JP, Malaval L, Clement-Lacroix P, Samarut J, Chassaude O, Willians GR. Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism. Mol Endocrinol 2007;21:1095–1107.
   Google Scholar
• Takkouche B, Montes-Martínez A, Gill SS, Etminan M. Psychotropic medications and the risk of fracture: a meta-analysis. Drug Saf 2007;30:171–184.
   PubMed Web of Science ®Google Scholar
• Goldhahn J, Little D, Mitchell P, Fazzalari NL, Reid IR, Aspenberg P, Marsh D. ISFR working group drugs and fracture repair. Evidence for anti-osteoporosis therapy in acute fracture situations—recommendations of a multidisciplinary workshop of the International Society for Fracture Repair. Bone 2010;46:267–271.
   PubMed Web of Science ®Google Scholar
• Kok C, Sambrook PN. Secondary osteoporosis in patients with an osteoporotic fracture. Best Pract Res Clin Rheumatol 2009;23:769–779.
   PubMed Web of Science ®Google Scholar
• Franco CB, Paz-Filho G, Gomes PE, Nascimento VB, Kulak CA, Boguszewski CL, Borba VZ. Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int 2009;20:1881–1887.
   PubMed Web of Science ®Google Scholar
• Sosa M, Saavedra P, Jódar E, Lozano-Tonkin C, Quesada JM, Torrijos A, Pérez-Cano R, Nogués X, Díaz-Curriel M, Moro MJ, Gómez C, Mosquera J, et al. Bone mineral density and risk of fractures in aging, obese post-menopausal women with type 2 diabetes. The GIUMO Study. Aging Clin Exp Res 2009;21:27–32.
   PubMed Web of Science ®Google Scholar
• Williams GR. Actions of thyroid hormones in bone. Endokrynol Pol 2009;60:380–388.
   PubMed Web of Science ®Google Scholar
• Nampei A, Hashimoto J, Koyanagi J, Ono T, Hashimoto H, Tsumaki N, Tomita T, Sugamoto K, Nishimoto N, Ochi T, Yoshikawa H. Characteristics of fracture and related factors in patients with rheumatoid arthritis. Mod Rheumatol 2008;18:170–176.
   PubMed Web of Science ®Google Scholar
• Bischoff L, Derk CT. Premenopausal osteoporosis. Minerva Med 2008;99:55–63.
   Google Scholar
• Alexander JL, Dennerstein L, Woods NF, Halbreich V, Kotz K, Richardson G, Graziottin A, Shermann JJ. Arthralgias, bodily aches and pains and somatic complaints in midlife women: etiology, pathophysiology and differential diagnosis. Expert Rev Neurother 2007;7(11 Suppl):S15–S26.
   Google Scholar
• Freeman EX, Sammel MD, Lin H, Gracia CR, Pieu GW, Nelson DB, Sheng L. Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol 2007;110:230–240.
   PubMed Web of Science ®Google Scholar
• Vondracek SF, Hansen LB, McDermott MT. Osteoporosis risk in premenopausal women. Pharmacotherapy 2009;29:305–317.
   PubMed Web of Science ®Google Scholar
• Gemalmaz A, Discigil G, Sensoy N, Basak O. Identifying osteoporosis in a primary care setting with quantitative ultrasound: relationship to anthropometric and lifestyle factors. J Bone Miner Metab 2007;25:184–192.
   Google Scholar
• Díez-Pérez A, González-Macías J, Marin F, Abizanda M, Alvarez R, Gimeno A, Pegenaute E, Vila J. Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound. Osteoporosis Int 2007;18:629–639.
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox J, Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ 2009;339:b4229.
   PubMed Web of Science ®Google Scholar
• Malik P, Gasser RW, Kemmler G, Moncayo R, Finkenstedt G, Kurz M, Fleischhacker WW. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study. Alcohol 2009;33:375–381.
   Google Scholar
• Gast GC, Grobbee DE, Pop VJ, Keyzer JJ, Wijnands-van Gent CJ, Samsioe GN, Nilsson PM, van der Schouw YT. Vasomotor symptoms are associated with a lower bone mineral density. Menopause 2009;16:231–238.
   PubMed Web of Science ®Google Scholar
• Crandall CJ, Zhen Y, Crawford SL, Thurston RC, Gold EB, Johnston JM, et al. Presence of vasomotor symptoms is associated with lower bone mineral density: a longitudinal analysis. Menopause 2009;16:239–246.
   PubMed Web of Science ®Google Scholar
• Nelson HD. Commonly used types of postmenopausal estrogen for treatment of hot flashes. JAMA 2004;291:1610–1620.
   PubMed Web of Science ®Google Scholar
• Nelson HD, Vesco KK, Haney E, Fu R, Nedrow A, Miller J, Nicolaidis C, Walker M, Humphrey L. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006;295:2057–2071.
   PubMed Web of Science ®Google Scholar
• Siris ES, Baim S, Nattiv A. Primary care use of FRAX: absolute fracture risk assessment in post- menopausal women and older men. Postgrad Med 2010; 122:82–90.
   PubMed Web of Science ®Google Scholar